WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Charles Schwartz
300 Points

Contributions by role

Editor 300

Contributions by subject area

Genetics
Ethical Issues
Medical Genetics
Pediatrics
Translational Medicine

Charles E. Schwartz


Summary

Greenwood Genetic Center, Former Director of Research; Adjunct Professor of Biology, University of South Carolina; Director, American Board of Medical Genetics, 2006-2011 and President 2009; Robert Guthrie Award for Advances in Biochemical and Molecular Genetics, 2003.

Genetics Medical Genetics Molecular Biology

Editing Journals

Work details

None

Retired
None

PeerJ Contributions

  • Edited 3

Academic Editor on

November 15, 2019
Differences in the importance of microcephaly, dysmorphism, and epilepsy in the detection of pathogenic CNVs in ID and ASD patients
Zuzana Capkova, Pavlina Capkova, Josef Srovnal, Katerina Staffova, Vera Becvarova, Marie Trkova, Katerina Adamova, Alena Santava, Vaclava Curtisova, Marian Hajduch, Martin Prochazka
https://doi.org/10.7717/peerj.7979 PubMed 31741789
January 9, 2019
MLPA is a practical and complementary alternative to CMA for diagnostic testing in patients with autism spectrum disorders and identifying new candidate CNVs associated with autism
Pavlina Capkova, Josef Srovnal, Zuzana Capkova, Katerina Staffova, Vera Becvarova, Marie Trkova, Katerina Adamova, Alena Santava, Vaclava Curtisova, Marian Hajduch, Martin Prochazka
https://doi.org/10.7717/peerj.6183 PubMed 30647996
April 22, 2014
A new direction for prenatal chromosome microarray testing: software-targeting for detection of clinically significant chromosome imbalance without equivocal findings
Joo Wook Ahn, Susan Bint, Melita D. Irving, Phillipa M. Kyle, Ranjit Akolekar, Shehla N. Mohammed, Caroline Mackie Ogilvie
https://doi.org/10.7717/peerj.354 PubMed 24795849